Patient Advocates from Greece, Germany, the UK, the Netherlands, Romania and other countries of the WHO European Region exchange thoughts and opinions with TIF about the daunting challenges and concerns the pandemic has brought about for thalassaemia and sickle cell disease patients in these areas.
Emerging Challenges & Future Therapies in Haemoglobinopathies The Focus of the ASCAT 2020 Conference
October 27, 2020
34 year old Victoria Gray will be the first American to get controversial gene-editing treatment for sickle cell disease
July 30, 2019